Clincosm LogoSign in Get a demo

Tuberculosis

Showing NaN - NaN of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
  • Placebo
  • Bandung, Indonesia
  • +59 more
Sep 25, 2023

HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)

Not yet recruiting
  • HIV I Infection
  • Tuberculosis
  • MTBVAC
  • BCG
  • Westdene, Gauteng,, South Africa
  • +15 more
Jul 21, 2023

Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Linezolid 600 mg
  • +7 more
  • Gaborone, South-East District, Botswana
  • +16 more
Dec 13, 2022

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • HIV Infections
  • VPM1002 Vaccine
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +8 more
Sep 14, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Recruiting
  • Drug Resistant Tuberculosis
  • +3 more
  • Xpert® MTB/XDR
  • Gulele, Addis Ababa, Ethiopia
  • +3 more
Jun 13, 2022

Tuberculosis, Hiv Trial in Durban (Dolutegravir 50 MG)

Recruiting
  • Tuberculosis
  • Hiv
  • Dolutegravir 50 MG
  • Durban, KwaZulu-Natal, South Africa
    King Edward VIII Hospital
May 18, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))

Completed
Has Results
  • HIV Infections
  • Tuberculosis
  • Levonorgestrel (LNG)
  • Chicago, Illinois
  • +17 more
Dec 22, 2021

Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))

Completed
Has Results
  • Tuberculosis
  • HIV Infections
  • Rifapentine (RPT)
  • +2 more
  • La Jolla, California
  • +44 more
Nov 2, 2021

HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)

Completed
  • HIV Infections
  • Tuberculosis
  • Efavirenz (EFV)
  • Rifampin-containing anti-TB therapy
  • Pune, Maharashtra, India
  • +6 more
Oct 28, 2021

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
Has Results
  • Tuberculosis
  • San Francisco, California
  • +32 more
Sep 1, 2021

HIV, Tuberculosis Trial in Durban (Quality Improvement Model of Care)

Completed
  • HIV
  • Tuberculosis
  • Quality Improvement Model of Care
  • Durban, KwaZulu Natal, South Africa
    CAPRISA eThekwini Clinical Research Site
Jan 29, 2021

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
Has Results
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

HIV-1 Infection, Tuberculosis Trial in Worldwide (Depot medroxyprogesterone acetate)

Completed
Has Results
  • HIV-1 Infection
  • Tuberculosis
  • Depot medroxyprogesterone acetate
  • Gaborone, Botswana
  • +4 more
Jun 13, 2019

Tuberculosis Trial in South Africa (Isoniazid, Rifapentine)

Unknown status
  • Tuberculosis
  • Durban, KwaZulu-Natal, South Africa
  • +4 more
Dec 20, 2018

Tuberculosis Trial in Durban (Test-and-Treat TB)

Completed
  • Tuberculosis
  • Test-and-Treat TB
  • Durban, KwaZulu-Natal, South Africa
    iThembalabantu Clinic/AIDS Healthcare Foundation
Apr 2, 2018

HIV Infection, Tuberculosis Trial in Worldwide (Standard-dose Lopinavir/Ritonavir, Double-dose Lopinavir/Ritonavir, Raltegravir)

Terminated
Has Results
  • HIV Infection
  • Tuberculosis
  • Standard-dose Lopinavir/Ritonavir
  • +8 more
  • Porto Alegre, RS, Brazil
  • +8 more
Feb 7, 2018

Highly Active Antiretroviral Therapy

Completed
  • Tuberculosis
    • Durban, KwaZulu Natal, South Africa
      CAPRISA eThekwini Clinical Research Site
    Feb 1, 2017

    Tuberculosis Trial in Worldwide (TMC207, Background Regimen (BR) for MDR-TB)

    Completed
    Has Results
    • Tuberculosis
    • TMC207
    • Background Regimen (BR) for MDR-TB
    • Beijing, China
    • +26 more
    Apr 8, 2015

    Diagnostics in HIV-Infected Individuals

    Completed
    • HIV Infections
    • Tuberculosis
    • Standardized diagnostic evaluation
    • Gaborone, Botswana
    • +12 more
    Mar 17, 2015

    Tuberculosis Trial in Worldwide (TMC207, Placebo, Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis))

    Completed
    Has Results
    • Tuberculosis
    • Rio De Janeiro, Brazil
    • +15 more
    Apr 10, 2014

    Tuberculosis Trial in South Africa, Zambia, Zimbabwe (Xpert MTB/RIF assay, Smear microscopy)

    Completed
    • Tuberculosis
    • Xpert MTB/RIF assay
    • Smear microscopy
    • Durban, Kwazulu-Natal, South Africa
    • +3 more
    Jun 4, 2013

    Tuberculosis Trial in Worldwide (Moxifloxacin (with rifampin, pyrazinamide, and ethambutol), isoniazid)

    Completed
    • Tuberculosis
    • Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)
    • isoniazid
    • Little Rock, Arkansas
    • +25 more
    Aug 2, 2011